Pre-conception and early pregnancy effects
The negative impact of toxic substances can begin long before actual pregnancy occurs. Mutagenic action is characterized by direct damage to the genetic apparatus (DNA). This effect affects the germ cells of partners before conception and can also spread to somatic cells.
In the event of successful fertilization, a period of potential embryotoxic action begins (the term originates from the Greek word embryon, meaning "embryo"). This type of toxic influence covers the first twelve weeks of the first trimester, but its specificity is most pronounced in the earliest stages—from the first to the third week of pregnancy.
During this time interval, corresponding to the blastocyst stage, the fertilized egg (zygote) is localized in the lumen of the fallopian tubes and uterine cavity until implantation is complete. Drug exposure during this period obeys the strict "all or nothing" principle: gross developmental disorders inevitably lead to the death of the embryo, or, if damage is avoided, it continues to develop completely normally. Drugs with a proven embryotoxic effect include antimitotic agents (e.g., colchicine) and antimetabolites (mercaptopurine, fluorouracil).
Teratogenic action and organogenesis disorders
The term teratogenic action originates from the Greek root teras, meaning "monster". This effect is a gross disruption of the formation processes of organs and systems—organogenesis. As a result of such interference, severe congenital skeletal malformations and major anomalies in the development of the internal organs of the embryo occur.
The physiological context of this phenomenon is due to the fact that the critical period for the development of teratogenic effects falls between the third and twelfth weeks, with the absolute peak of danger being weeks 4–8 of pregnancy. It is during this time frame that active laying down of internal organs and the formation of skeletal elements occur, making embryonic tissues maximally sensitive to damaging factors.
The high-risk group includes antineoplastic agents, particularly folic acid antagonists (a typical representative being methotrexate). Special attention should be paid to ethyl alcohol: its intake is extremely dangerous, especially if it coincides with the moment of conception.
Historical example: the thalidomide tragedy
The most famous, large-scale, and tragic example of the catastrophic realization of a delayed embryotoxic effect (type D) was the "thalidomide catastrophe", which unfolded between 1956 and 1962.
The drug thalidomide was massively prescribed to pregnant women in early pregnancy as an effective antiemetic and sedative (sleeping aid). The geography of its use covered Western Europe, America, and Australia. The consequence of taking this drug was the birth of many children with specific congenital limb malformations.
This pathology received the medical name phocomelia (the term is formed from the Greek words phoke — "seal", and melos — "limb" or "body part"). In phocomelia, the child's arms and legs remain underdeveloped and visually strongly resemble seal flippers.
Fetotoxic action in late stages
As the critical first trimester and the basic formation of all anatomical structures of the body come to a close, the fetal period begins. It starts after the twelfth week of pregnancy and continues until childbirth.
The negative impact of medications at this stage is classified as fetotoxic action. Its key difference is the absence of gross anatomical deformations, since the fetal organs have already formed. Instead, the drugs provoke a disruption in the normal functioning of body structures or significantly delay the maturation processes of already fully formed fetal organs.
Briefly: answers to topical questions
Which pharmacological groups and drugs have an embryotoxic effect?
Antimetabolites, antimitotic agents, as well as certain antiviral drugs and anticoagulants, have an embryotoxic effect. Drugs with proven or potential embryotoxic effects leading to gross developmental disorders or embryo death include:
- Antimetabolites — mercaptopurine, fluorouracil.
- Antimitotic agents — colchicine.
- Antiviral agents — ribavirin.
- Anticoagulants — warfarin.
Which drugs have a teratogenic effect?
A wide range of medications from various pharmacological groups have a teratogenic effect. Drugs that cause developmental anomalies include:
- Hypnotics — thalidomide.
- Antineoplastic and immunosuppressive agents — methotrexate, cyclophosphamide, mycophenolate mofetil, leflunomide.
- Antihypertensive agents — ACE inhibitors (lisinopril, captopril, benazepril, enalapril) and ARBs (losartan, valsartan, candesartan).
- Psychotropic drugs — lithium salts (Lithium).
- Vitamin preparations — retinoids (Retinoids), isotretinoin.
- Antimicrobial and antiviral agents — streptomycin, ribavirin, efavirenz, pyrimethamine + sulfadiazine combination.
- Antiepileptic drugs — carbamazepine.
Ethyl alcohol also has a teratogenic effect.
Which medications cause a fetotoxic effect?
Fetotoxic effects are caused by drugs that disrupt the functions or maturation of already formed organs in the late stages of pregnancy. Such medications include:
- Anticoagulants (including warfarin) — cause a risk of bleeding in the newborn due to reduced blood clotting.
- Sulfonylurea derivatives — provoke a risk of hypoglycemia in the fetus.
- Neurotropic agents (alcohol, drugs, sleeping aids) — lead to depression of the central nervous system of the fetus.
What categories of risk for drug use during pregnancy does the FDA distinguish?
The sources indicate the following FDA pregnancy risk categories:
| Category | Safety profile | Drug examples |
|---|---|---|
| A | Safety proven | Potassium chloride, iron preparations |
| B | Relatively safe | Insulin, acetylsalicylic acid, metronidazole |
| C | Potential risk; administration is possible if the benefit outweighs the risk | — |
| D | Proven risk; use is possible for life-saving indications if the benefit outweighs the risk | Diazepam, efavirenz |
| X | Strictly contraindicated | Isotretinoin, carbamazepine, streptomycin |
It is specifically indicated that category N means the drug is unclassified; an example is elsulfavirine.
Chronological rule "METF": Mutagenic (pre-conception) → Embryotoxic (1–3 weeks) → Teratogenic (3–12 weeks) → Fetotoxic (from 12 weeks to birth).
Class and exam questions
What is the essence of the "all-or-none" principle in embryotoxic action?
This means that the toxic effect of the drug at the blastocyst stage (1–3 weeks) either causes gross disorders leading to the death of the embryo, or leaves no consequences, and further development proceeds absolutely normally.
At what gestational age are tissues most sensitive to teratogens?
Tissues exhibit maximum sensitivity to damaging factors during active organogenesis — at 4–8 weeks of gestation (within the first trimester).
How does fetotoxic action differ from teratogenic action?
Teratogenic action disrupts organ formation (causes malformations) in the first trimester. Fetotoxic action occurs in the fetal period (after 12 weeks) and disrupts only the functions or maturation of already formed organs.
What else to study on this topic
- Mechanisms of germ cell DNA damage prior to conception
- Effects of antimetabolites and antimitotic agents on the zygote
- Specific teratogenic effects of folic acid antagonists (methotrexate)
- Impact of ethanol at the time of conception on embryonic development
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Effects of Drugs on the Fetus" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in "General Pharmacology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.